Company Overview - Medline has been a private company for 58 years with consecutive growth and is now seeking to go public to expand its voice and market presence [1][2] - The company aims to be the "Costco of healthcare," utilizing a membership model that provides value and savings to its customers [5] Financial Performance - Medline has a 99% customer retention rate and offers over 335,000 products from 29 million square feet of warehouse space in the US [6] - The company's margins are designed to support ongoing investments in the business, with a current margin of approximately 13% [7][8] - As of September, Medline reported a net debt of about $15 billion and a net debt to EBITDA ratio of 4.8%, with plans to reduce this to 3.25 through a $5 billion IPO, allocating $4 billion for debt reduction [10] Market Position and Strategy - Medline positions itself as a value player in the healthcare market, focusing on cost and price competitiveness [8] - The healthcare industry is facing challenges such as reimbursement cuts and shifts in care delivery, which Medline aims to navigate by providing timely and valuable solutions to its customers [12][13]

All right, welcome back to Worldwide Exchange. As we close on the 6 a. m.hour, a check on a few big stories that we're following this morning. Sources tell CNBC Open AI is in talks to raise at least $10 billion from Amazon and use its chips. Open AAI has so far declined to comment.A deal could value OpenAI at more than $500 billion and see it adopt Amazon's Tranium chip, a story that we're continue to follow throughout the morning. All right, Whimo is in talks to raise $15 billion in funding in the new year ...

Group 1 - OpenAI is in discussions to raise at least $10 billion from Amazon, potentially valuing the company at over $500 billion and adopting Amazon's Tranium chip [1][2] - Whimo, the self-driving car company owned by Alphabet, is planning to raise $15 billion in funding, aiming for a valuation of up to $110 billion [2] - Warner Brothers Discovery intends to recommend its shareholders reject Paramount's hostile takeover offer and support its existing deal with Netflix [3] Group 2 - Spirit Airlines has revived merger talks with Frontier Airlines, with a potential deal announcement expected soon [4] - Robinhood has introduced new prediction market features for users to place bets on NFL games, positioning itself against traditional sportsbooks [5] - Medline has priced its IPO at $29 per share, raising $6.3 billion, making it the largest offering of the year and giving it a valuation exceeding $50 billion [5][6]

Core Viewpoint - Medline is set to debut on the Nasdaq after raising $6.26 billion in the largest global initial public offering of 2025, marking a strong year for new listings [1] Group 1 - The IPO raised $6.26 billion, making it the biggest IPO globally in 2025 [1] - This event highlights a robust market for new listings in the current year [1]

Core Viewpoint - Medline Inc. has announced the pricing of its upsized initial public offering (IPO) of 216,034,482 shares of Class A common stock at a price of $29.00 per share, with trading expected to begin on December 17, 2025, under the symbol "MDLN" [1]. Group 1: IPO Details - The underwriters have been granted a 30-day option to purchase an additional 32,405,172 shares of Class A common stock [1]. - Medline plans to use the proceeds from the issuance of 179,000,000 shares to repay outstanding indebtedness under its senior secured term loan facilities, with the remainder allocated for general corporate purposes and offering expenses [1]. - The offering is expected to close on December 18, 2025, subject to customary closing conditions [1]. Group 2: Underwriters and Managers - Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan are acting as global coordinators and lead bookrunning managers for the offering [2]. - A number of other financial institutions are involved as bookrunning managers and co-managers for the proposed offering [2]. Group 3: Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, serving all points of care [5]. - The company has a broad product portfolio, resilient supply chain, and leading clinical solutions aimed at improving healthcare providers' clinical, financial, and operational outcomes [5]. - Medline is headquartered in Northfield, Illinois, employs over 43,000 people worldwide, and operates in more than 100 countries [5].

Core Insights - Solventum has achieved the Diamond Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC), marking the highest recognition for supply chain strength in healthcare [1][2] - This certification validates Solventum's MedSurg segment's capability to deliver critical healthcare products consistently, even during supply disruptions [1][3] Company Achievements - The Diamond Level Badge is awarded based on a rigorous assessment of resiliency across key domains such as demand planning, inventory management, logistics visibility, supplier management, and risk mitigation [3] - Solventum's Chief Supply Chain Officer emphasized the company's investment in visibility tools, risk management processes, and contingency planning to ensure customer needs are met [4] - The Diamond Level Badge was received across all MedSurg product lines, including negative pressure wound therapy, advanced wound dressings, and surgical solutions [4] Industry Impact - The achievement of the Diamond Level Badge signals to customers that Solventum has the right team and infrastructure to navigate future challenges in the healthcare supply chain [5] - The recognition reflects the company's commitment to operational strength and proactive risk management, ensuring continuity of patient care [2][3]

Private equity-owned medical supplies giant Medline is targeting an offering of up to $7 billion in an upsized share sale, the Financial Times reported on Tuesday, citing people briefed on the talks. ...

Company Overview - Medline is a medical supply company that manufactures and distributes products such as masks, gowns, and lab kits [3] - The company was taken private in 2021 by a consortium of private equity firms, including Blackstone, Carlyle, and Hellman & Friedman, marking the largest leveraged buyout (LBO) post-financial crisis [3][4] IPO Details - The IPO is expected to price tonight and could be one of the largest debuts in the public markets this year, potentially valued at $55 billion, which is over $20 billion higher than the acquisition price by its sponsors [1][4] - The IPO guidance suggests pricing toward the high end of the range, indicating strong investor interest [2] Business Performance - Medline has demonstrated a resilient business model, with net sales growing each year since its inception in the 1960s at a compound annual growth rate (CAGR) of 18% [4] - The company is expected to benefit from secular tailwinds such as an aging population and the consolidation of healthcare providers [5] Growth Strategy - Medline's growth strategy includes acquiring several companies and continuing this trend to enhance its market position [5] - The concentration within Medline's business and its customer base is viewed as both a potential advantage and a risk factor [6] Market Context - The IPO is seen as a critical test for the IPO market, which has a healthy backlog of deals for 2026, and for the private equity industry, which has faced challenges in finding exits for portfolio companies [4]

Summary of Key Points Core Viewpoint - The article discusses the recent IPO activities, highlighting that 10 new stocks were listed last week, with 9 of them raising over $100 million each. Group 1: Recent IPOs - JM Group (JMG) raised $15 million by issuing 3.75 million shares at $4 per share [1] - Wealthfront (WLTH) raised $485 million by issuing 34.62 million shares at $14 per share [2] - Lumexa Imaging Holdings (LMRI) raised $463 million by issuing 25 million shares at $18.5 per share [2] - Cardinal Infrastructure (CDNL) raised $242 million by issuing 11.5 million shares at $21 per share [2] - SPACs Bluerock Acquisition (BLRKU), Carbon Capital Partner (KBONU), Meshflow Acquisition (MESHU), Daedalus Special Acquisition (DSACU), ITHAX Acquisition III (ITHAU), and Twelve Seas III (TWLVU) raised $150 million, $300 million, $300 million, $225 million, $200 million, and $150 million respectively [2] Group 2: Upcoming IPOs - Andersen Group Inc., a tax consulting firm, plans to go public on December 17, 2025, on the NYSE under the ticker ANDG, aiming to raise approximately $176 million by issuing 11 million shares at $14 to $16 per share [3][6] - Medline Inc., a leading medical supplies manufacturer, plans to go public on December 17, 2025, on NASDAQ under the ticker MDLN, aiming to raise approximately $5.37 billion by issuing 17.9 million shares at $26 to $30 per share [8][11]

Ukraine's health supplies hit in series of Russian strikes on medical warehouses https://t.co/Wnfv1RqG1d ...